{"article_link": "https://doi.org/10.1038/s41591-021-01329-2", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://covid19cellatlas.org/", "format": "h5ad", "source": "ArrayExpress", "public_id": "E-MTAB-10026"}, {"id": "data_2", "omics": "Proteomics", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "Custom CITE-seq", "public_id": "E-MTAB-10026"}, {"id": "data_3", "omics": "Immunomics (TCR)", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "10x Genomics", "public_id": "E-MTAB-10026"}, {"id": "data_4", "omics": "Immunomics (BCR)", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "10x Genomics", "public_id": "E-MTAB-10026"}, {"id": "data_5", "omics": "Multi-omics", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "Combined Transcriptomics, Proteomics, and Immunomics", "public_id": "E-MTAB-10026"}], "analyses": [{"id": "analysis_1", "analysis_name": "Single-cell transcriptome and surface proteome analysis", "analysis_data": ["data_1", "data_2"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_2", "analysis_name": "Cell clustering and annotation", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_3", "analysis_name": "Differential abundance testing", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_4", "analysis_name": "Gene Set Enrichment Analysis (GSEA)", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_5", "analysis_name": "Cydar analysis", "analysis_data": ["data_2"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_6", "analysis_name": "TCR clonality analysis", "analysis_data": ["data_3"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_7", "analysis_name": "BCR clonality and mutation analysis", "analysis_data": ["data_4"], "label": {"gender": ["female", "male"], "severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_8", "analysis_name": "Interferon, TNF, and JAK–STAT response scoring", "analysis_data": ["data_1"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_9", "analysis_name": "kBET analysis", "analysis_data": ["data_1", "data_2"], "label": {"batch_factor": ["site"]}}, {"id": "analysis_10", "analysis_name": "Bronchoalveolar lavage (BAL) data comparison", "analysis_data": ["data_1", "data_2"], "label": {"source": ["GSE145926"]}}, {"id": "analysis_11", "analysis_name": "CellPhoneDB receptor-ligand interaction analysis", "analysis_data": ["data_2"], "label": {"cell_type": ["monocytes", "platelets"]}}, {"id": "analysis_12", "analysis_name": "Platelet activation analysis", "analysis_data": ["data_2"], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_13", "analysis_name": "HSPC commitment scoring", "analysis_data": ["data_1", "data_2"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_14", "analysis_name": "Multiplex cytokine analysis", "analysis_data": ["data_2"], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_15", "analysis_name": "Restimulation of PBMCs with SARS-CoV-2 peptide", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_16", "analysis_name": "Flow cytometry validation", "analysis_data": ["data_1", "data_2", "data_3"], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_17", "analysis_name": "Differential correlation analysis", "analysis_data": ["data_1", "data_2"], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}], "results": [{"analysis_id": "analysis_1", "metrics": "Fold change", "value": "1.81 (CD8+ T cells), 0.87 (CD8+ TEM cells)", "features": ["CD14+ monocytes", "CD16+ monocytes", "plasmablasts", "B cells", "CD8+ T cells", "CD4+ T cells", "NK cells", "HSPCs"]}, {"analysis_id": "analysis_2", "metrics": "", "value": "", "features": ["CD16+ monocyte expansion in severe disease", "proliferating monocytes", "innate lymphoid cell subpopulations", "isotype-specific plasma cells"]}, {"analysis_id": "analysis_3", "metrics": "Odds ratio", "value": "1.81 (CD8+ T cells), 0.87 (CD8+ TEM cells)", "features": ["CD8+ T cells", "CD8+ TEM cells", "plasmablasts", "plasma cells"]}, {"analysis_id": "analysis_4", "metrics": "Normalized enrichment score (NES)", "value": "0.75", "features": ["IL-2–STAT5 signaling in CD4+ T cells", "mTORC1 signaling in myeloid cells", "IFNγ response in B cells", "IL-6–JAK–STAT3 signaling in monocytes"]}, {"analysis_id": "analysis_5", "metrics": "Spatial FDR", "value": "<0.05", "features": ["608 hyperspheres associated with severity", "B cells in plasmablast expansion", "HSPCs in megakaryocyte priming"]}, {"analysis_id": "analysis_6", "metrics": "Odds ratio", "value": "1.81 (CD8+ T cells), 0.87 (CD8+ TEM cells)", "features": ["CD8+ T cells", "CD8+ TEM cells", "TE:EM ratio correlated with severity"]}, {"analysis_id": "analysis_7", "metrics": "", "value": "", "features": ["IGHV1-46 gene usage in women with critical disease", "clonotype size gini indices", "node closeness centrality"]}, {"analysis_id": "analysis_8", "metrics": "Normalized enrichment score (NES)", "value": "0.75", "features": ["Type I/III IFN response in monocytes", "TNF signaling in B cells", "JAK–STAT response in HSPCs"]}, {"analysis_id": "analysis_9", "metrics": "Wilcoxon paired signed-rank test", "value": "P < 2.1 × 10^-8", "features": ["Improved cell mixing by site after integration", "rejection rate improvement"]}, {"analysis_id": "analysis_10", "metrics": "", "value": "", "features": ["CD16+ monocytes aligning with BAL macrophages", "expression of FCGR3A", "C1QA/B/C", "type I IFN response genes in monocytes"]}, {"analysis_id": "analysis_11", "metrics": "", "value": "", "features": ["SIRPA:CD47 interactions in monocytes", "FPR1:ANXA1", "ICAM1 in platelet-monocyte aggregates"]}, {"analysis_id": "analysis_12", "metrics": "", "value": "", "features": ["Platelet activation markers (PF4, GP9)", "CD34+ HSPC expansion in symptomatic patients"]}, {"analysis_id": "analysis_13", "metrics": "ANOVA with Tukey’s test", "value": "P = 2.92 × 10^-18", "features": ["TE:EM ratio in CD8+ T cells", "CD8+ TTE differentiation", "CD8+ TEM depletion"]}, {"analysis_id": "analysis_14", "metrics": "", "value": "", "features": ["CCL4 elevation in severe disease", "CXCL10 in moderate disease", "IL-7 in asymptomatic patients"]}, {"analysis_id": "analysis_15", "metrics": "Fold change", "value": "0.0051 (CD137 expression)", "features": ["CD137 upregulation in CD8+ T cells", "CD107a in antigen-specific T cells"]}, {"analysis_id": "analysis_16", "metrics": "Percentage of cells", "value": "50,000–60,000 cells per pool", "features": ["CD137 and CD107a in activated CD8+ T cells", "validation of T cell activation"]}, {"analysis_id": "analysis_17", "metrics": "Pearson correlation", "value": "0.8", "features": ["TFH-plasmablast correlation in asymptomatic patients", "loss in severe disease"]}]}